McKesson Corporation (MCK): Price and Financial Metrics


McKesson Corporation (MCK)

Today's Latest Price: $153.04 USD

0.62 (0.41%)

Updated Oct 20 4:03pm

Add MCK to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 70 in Medical - Services

See all "A" rated Strong Buy stocks

MCK Stock Summary

  • Mckesson Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than 99.32% of US listed stocks.
  • MCK's price/sales ratio is 0.11; that's higher than the P/S ratio of only 3.22% of US stocks.
  • The volatility of Mckesson Corp's share price is greater than that of only 2.35% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to MCK, based on their financial statements, market capitalization, and price volatility, are SYY, ABC, MAT, BGI, and DXLG.
  • MCK's SEC filings can be seen here. And to visit Mckesson Corp's official web site, go to www.mckesson.com.

MCK Stock Price Chart Interactive Chart >

Price chart for MCK

MCK Price/Volume Stats

Current price $153.04 52-week high $172.18
Prev. close $152.42 52-week low $112.60
Day low $152.57 Volume 786,943
Day high $155.40 Avg. volume 2,497,040
50-day MA $151.52 Dividend yield 1.1%
200-day MA $148.01 Market Cap 24.82B

McKesson Corporation (MCK) Company Bio


Mckesson Corporation partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. The company was founded in 1833 and is based in San Francisco, California.

MCK Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$153.04$139.01 -9%

Below please find a table outlining a discounted cash flow forecast for MCK, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Mckesson Corp ranked in the 44th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for MCK, they are:

  • Its compound free cash flow growth rate, as measured over the past 5.5 years, is -0.03% -- higher than just 21.21% of stocks in our DCF forecasting set.
  • The company has produced more trailing twelve month cash flow than 88.96% of its sector Healthcare.
  • Mckesson Corp's weighted average cost of capital (WACC) is 7%; for context, that number is higher than merely 13.47% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-11%
1%-10%
2%-9%
3%-8%
4%-7%
5%-6%

Want more companies with a valuation profile/forecast similar to that of Mckesson Corp? See MEDP, DXCM, AMED, HBIO, and USPH.


MCK Latest News Stream


Event/Time News Detail
Loading, please wait...

MCK Latest Social Stream


Loading social stream, please wait...

View Full MCK Social Stream

Latest MCK News From Around the Web

Below are the latest news stories about Mckesson Corp that investors may wish to consider to help them evaluate MCK as an investment opportunity.

Specialty Drug Distribution Market Business Growth, Size and Comprehensive Research Study Forecast to 2026| Amerisource, Mckesson, Cardinal Health

Specialty Drug Distribution Market is expected to grow significantly over next few years and generate considerable market for Specialty Drug Distribution. Market Report Expert has recently published a research report titled, “Specialty Drug Distribution Market Outlook and Statistics, 2020-2026". The report

OpenPR | October 2, 2020

Growth Aspects of IT Spending in Remote Healthcare Delivery Market is Blossoming Worldwide with GE Healthcare, McKesson, Philips Healthcare, Siemens Healthcare, Aerotal Medical Systems, Agfa-Gevaert, AMD Telemedicine, Bosch Healthcare

IT Spending in Remote Healthcare Delivery involves the distribution of health-related services and information via electronic information and telecommunication technologies. It allows long-distance patient/clinician contact and care, advice, reminders, education, intervention, monitoring, and remote admissions. As well as provider distance-learning;

OpenPR | October 1, 2020

Global Telemental Health Market 2020-2027 Major Players Hitting the Reset Button || AMD Global Telemedicine, Inc (US), Aerotel Medical Systems (1998) Ltd. (Israel), Medtronic (Ireland), F. Hoffmann-La Roche Ltd. (Switzerland), McKesson Corporation

According to this Global Telemental Health Market report, the key market players are making moves like product launches, joint ventures, developments, mergers and acquisitions which has influence on the market and Industry as a whole and also affecting the sales,

OpenPR | September 28, 2020

McKesson Ventures Grows Leadership Team with New Partner Promotions

SAN FRANCISCO--(BUSINESS WIRE)--McKesson Ventures, the venture capital arm of McKesson Corporation, announces the expansion of its leadership team, promoting Jennifer Carter and Carrie Hurwitz Williams to partners of McKesson Ventures. The new partner roles exemplify McKesson Ventures’ growth since it was established in 2014. As partner, Carter and Williams will identify long-term strategic industry opportunities, invest in healthcare technology companies and build valuable partnerships with Mc

Business Wire | September 16, 2020

McKesson: On Solid Ground

Good businesses will survive good times and bad times. − Theo Paphitis A global leader in the U.S. healthcare and pharmaceutical supply chain, McKesson Corporation (MCK) operates a low-margin, high-volume business. The company is expected to witness a solid rise in volumes in Q4 2020 because it has partnered with...

Michael A. Gayed, CFA on Seeking Alpha | September 7, 2020

Read More 'MCK' Stories Here

MCK Price Returns

1-mo 0.60%
3-mo -1.79%
6-mo 12.66%
1-year 5.00%
3-year 4.91%
5-year -11.57%
YTD 11.55%
2019 26.72%
2018 -28.40%
2017 11.95%
2016 -28.30%
2015 -4.51%

MCK Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full MCK Dividend History

Continue Researching MCK

Here are a few links from around the web to help you further your research on Mckesson Corp's stock as an investment opportunity:

Mckesson Corp (MCK) Stock Price | Nasdaq
Mckesson Corp (MCK) Stock Quote, History and News - Yahoo Finance
Mckesson Corp (MCK) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8065 seconds.